Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data

BackgroundIn questionable cystic fibrosis (CF), mild or monosymptomatic phenotypes frequently cause diagnostic difficulties despite detailed algorithms. CF transmembrane conductance regulator (CFTR)-mediated ion transport can be studied ex vivo in rectal biopsies by intestinal current measurement (I...

Full description

Saved in:
Bibliographic Details
Published inThorax Vol. 65; no. 7; pp. 594 - 599
Main Authors Derichs, Nico, Sanz, Javier, Von Kanel, Thomas, Stolpe, Cornelia, Zapf, Antonia, Tümmler, Burkhard, Gallati, Sabina, Ballmann, Manfred
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group 01.07.2010
BMJ Publishing Group LTD
Subjects
Online AccessGet full text
ISSN0040-6376
1468-3296
1468-3296
DOI10.1136/thx.2009.125088

Cover

Abstract BackgroundIn questionable cystic fibrosis (CF), mild or monosymptomatic phenotypes frequently cause diagnostic difficulties despite detailed algorithms. CF transmembrane conductance regulator (CFTR)-mediated ion transport can be studied ex vivo in rectal biopsies by intestinal current measurement (ICM).ObjectivesTo describe reference values and validate ICM for the diagnostic classification of questionable CF at all patient ages.MethodsICM was performed in 309 rectal biopsies from 130 infants, children and adults including patients with known pancreatic-insufficient (PI)-CF (n=34), pancreatic-sufficient (PS)-CF (n=7), patients with an unclear diagnosis with mild CF symptoms, intermediate sweat test and/or CFTR mutation screening (n=61) and healthy controls (n=28). ICM was correlated to sweat chloride, extensive CFTR genotype and transcript analysis in the diagnostic group. The results were compared with previous ICM data in subjects with CF, congenital bilateral absence of the vas deferens, heterozygotes and controls.ResultsThe cumulative chloride secretory response of ΔIsc,carbachol, ΔIsc,cAMP/forskolin and ΔIsc,histamine was the best diagnostic ICM parameter (cut-off 34 μA/cm2 between patients with known PS-CF and controls), differentiating patients with questionable CF into PS-CF (n=6) and ‘CF unlikely’ (n=55) groups. Extensive genotype analysis detected two mutations (40% disease-causing) in 100% of individuals classified as PS-CF compared with 1.8% in those classified as ‘CF unlikely’.ConclusionsThis comprehensive investigation of CFTR function and genotype underlines the diagnostic value of ICM, especially for confirmation of CF in the absence of two disease-causing CFTR mutations, exclusion of CF despite intermediate sweat test and age groups unsuitable for nasal potential difference measurements. ICM is an important tool for functional assessment in CFTR mutations of unknown clinical relevance.
AbstractList BackgroundIn questionable cystic fibrosis (CF), mild or monosymptomatic phenotypes frequently cause diagnostic difficulties despite detailed algorithms. CF transmembrane conductance regulator (CFTR)-mediated ion transport can be studied ex vivo in rectal biopsies by intestinal current measurement (ICM).ObjectivesTo describe reference values and validate ICM for the diagnostic classification of questionable CF at all patient ages.MethodsICM was performed in 309 rectal biopsies from 130 infants, children and adults including patients with known pancreatic-insufficient (PI)-CF (n=34), pancreatic-sufficient (PS)-CF (n=7), patients with an unclear diagnosis with mild CF symptoms, intermediate sweat test and/or CFTR mutation screening (n=61) and healthy controls (n=28). ICM was correlated to sweat chloride, extensive CFTR genotype and transcript analysis in the diagnostic group. The results were compared with previous ICM data in subjects with CF, congenital bilateral absence of the vas deferens, heterozygotes and controls.ResultsThe cumulative chloride secretory response of ΔIsc,carbachol, ΔIsc,cAMP/forskolin and ΔIsc,histamine was the best diagnostic ICM parameter (cut-off 34 μA/cm2 between patients with known PS-CF and controls), differentiating patients with questionable CF into PS-CF (n=6) and ‘CF unlikely’ (n=55) groups. Extensive genotype analysis detected two mutations (40% disease-causing) in 100% of individuals classified as PS-CF compared with 1.8% in those classified as ‘CF unlikely’.ConclusionsThis comprehensive investigation of CFTR function and genotype underlines the diagnostic value of ICM, especially for confirmation of CF in the absence of two disease-causing CFTR mutations, exclusion of CF despite intermediate sweat test and age groups unsuitable for nasal potential difference measurements. ICM is an important tool for functional assessment in CFTR mutations of unknown clinical relevance.
Background In questionable cystic fibrosis (CF), mild or monosymptomatic phenotypes frequently cause diagnostic difficulties despite detailed algorithms. CF transmembrane conductance regulator (CFTR)-mediated ion transport can be studied ex vivo in rectal biopsies by intestinal current measurement (ICM). Objectives To describe reference values and validate ICM for the diagnostic classification of questionable CF at all patient ages. Methods ICM was performed in 309 rectal biopsies from 130 infants, children and adults including patients with known pancreatic-insufficient (PI)-CF (n=34), pancreatic-sufficient (PS)-CF (n=7), patients with an unclear diagnosis with mild CF symptoms, intermediate sweat test and/or CFTR mutation screening (n=61) and healthy controls (n=28). ICM was correlated to sweat chloride, extensive CFTR genotype and transcript analysis in the diagnostic group. The results were compared with previous ICM data in subjects with CF, congenital bilateral absence of the vas deferens, heterozygotes and controls. Results The cumulative chloride secretory response of Î"Isc,carbachol , Î"Isc,cAMP/forskolin and Î"Isc,histamine was the best diagnostic ICM parameter (cut-off 34 μA/cm2 between patients with known PS-CF and controls), differentiating patients with questionable CF into PS-CF (n=6) and 'CF unlikely' (n=55) groups. Extensive genotype analysis detected two mutations (40% disease-causing) in 100% of individuals classified as PS-CF compared with 1.8% in those classified as 'CF unlikely'. Conclusions This comprehensive investigation of CFTR function and genotype underlines the diagnostic value of ICM, especially for confirmation of CF in the absence of two disease-causing CFTR mutations, exclusion of CF despite intermediate sweat test and age groups unsuitable for nasal potential difference measurements. ICM is an important tool for functional assessment in CFTR mutations of unknown clinical relevance.
In questionable cystic fibrosis (CF), mild or monosymptomatic phenotypes frequently cause diagnostic difficulties despite detailed algorithms. CF transmembrane conductance regulator (CFTR)-mediated ion transport can be studied ex vivo in rectal biopsies by intestinal current measurement (ICM).BACKGROUNDIn questionable cystic fibrosis (CF), mild or monosymptomatic phenotypes frequently cause diagnostic difficulties despite detailed algorithms. CF transmembrane conductance regulator (CFTR)-mediated ion transport can be studied ex vivo in rectal biopsies by intestinal current measurement (ICM).To describe reference values and validate ICM for the diagnostic classification of questionable CF at all patient ages.OBJECTIVESTo describe reference values and validate ICM for the diagnostic classification of questionable CF at all patient ages.ICM was performed in 309 rectal biopsies from 130 infants, children and adults including patients with known pancreatic-insufficient (PI)-CF (n=34), pancreatic-sufficient (PS)-CF (n=7), patients with an unclear diagnosis with mild CF symptoms, intermediate sweat test and/or CFTR mutation screening (n=61) and healthy controls (n=28). ICM was correlated to sweat chloride, extensive CFTR genotype and transcript analysis in the diagnostic group. The results were compared with previous ICM data in subjects with CF, congenital bilateral absence of the vas deferens, heterozygotes and controls.METHODSICM was performed in 309 rectal biopsies from 130 infants, children and adults including patients with known pancreatic-insufficient (PI)-CF (n=34), pancreatic-sufficient (PS)-CF (n=7), patients with an unclear diagnosis with mild CF symptoms, intermediate sweat test and/or CFTR mutation screening (n=61) and healthy controls (n=28). ICM was correlated to sweat chloride, extensive CFTR genotype and transcript analysis in the diagnostic group. The results were compared with previous ICM data in subjects with CF, congenital bilateral absence of the vas deferens, heterozygotes and controls.The cumulative chloride secretory response of DeltaI(sc,carbachol), DeltaI(sc,cAMP/forskolin) and DeltaI(sc,histamine) was the best diagnostic ICM parameter (cut-off 34 muA/cm(2) between patients with known PS-CF and controls), differentiating patients with questionable CF into PS-CF (n=6) and 'CF unlikely' (n=55) groups. Extensive genotype analysis detected two mutations (40% disease-causing) in 100% of individuals classified as PS-CF compared with 1.8% in those classified as 'CF unlikely'.RESULTSThe cumulative chloride secretory response of DeltaI(sc,carbachol), DeltaI(sc,cAMP/forskolin) and DeltaI(sc,histamine) was the best diagnostic ICM parameter (cut-off 34 muA/cm(2) between patients with known PS-CF and controls), differentiating patients with questionable CF into PS-CF (n=6) and 'CF unlikely' (n=55) groups. Extensive genotype analysis detected two mutations (40% disease-causing) in 100% of individuals classified as PS-CF compared with 1.8% in those classified as 'CF unlikely'.This comprehensive investigation of CFTR function and genotype underlines the diagnostic value of ICM, especially for confirmation of CF in the absence of two disease-causing CFTR mutations, exclusion of CF despite intermediate sweat test and age groups unsuitable for nasal potential difference measurements. ICM is an important tool for functional assessment in CFTR mutations of unknown clinical relevance.CONCLUSIONSThis comprehensive investigation of CFTR function and genotype underlines the diagnostic value of ICM, especially for confirmation of CF in the absence of two disease-causing CFTR mutations, exclusion of CF despite intermediate sweat test and age groups unsuitable for nasal potential difference measurements. ICM is an important tool for functional assessment in CFTR mutations of unknown clinical relevance.
In questionable cystic fibrosis (CF), mild or monosymptomatic phenotypes frequently cause diagnostic difficulties despite detailed algorithms. CF transmembrane conductance regulator (CFTR)-mediated ion transport can be studied ex vivo in rectal biopsies by intestinal current measurement (ICM). To describe reference values and validate ICM for the diagnostic classification of questionable CF at all patient ages. ICM was performed in 309 rectal biopsies from 130 infants, children and adults including patients with known pancreatic-insufficient (PI)-CF (n=34), pancreatic-sufficient (PS)-CF (n=7), patients with an unclear diagnosis with mild CF symptoms, intermediate sweat test and/or CFTR mutation screening (n=61) and healthy controls (n=28). ICM was correlated to sweat chloride, extensive CFTR genotype and transcript analysis in the diagnostic group. The results were compared with previous ICM data in subjects with CF, congenital bilateral absence of the vas deferens, heterozygotes and controls. The cumulative chloride secretory response of DeltaI(sc,carbachol), DeltaI(sc,cAMP/forskolin) and DeltaI(sc,histamine) was the best diagnostic ICM parameter (cut-off 34 muA/cm(2) between patients with known PS-CF and controls), differentiating patients with questionable CF into PS-CF (n=6) and 'CF unlikely' (n=55) groups. Extensive genotype analysis detected two mutations (40% disease-causing) in 100% of individuals classified as PS-CF compared with 1.8% in those classified as 'CF unlikely'. This comprehensive investigation of CFTR function and genotype underlines the diagnostic value of ICM, especially for confirmation of CF in the absence of two disease-causing CFTR mutations, exclusion of CF despite intermediate sweat test and age groups unsuitable for nasal potential difference measurements. ICM is an important tool for functional assessment in CFTR mutations of unknown clinical relevance.
Author Derichs, Nico
Ballmann, Manfred
Zapf, Antonia
Gallati, Sabina
Von Kanel, Thomas
Sanz, Javier
Stolpe, Cornelia
Tümmler, Burkhard
Author_xml – sequence: 1
  givenname: Nico
  surname: Derichs
  fullname: Derichs, Nico
  email: derichs.nico@mh-hannover.de
  organization: Cystic Fibrosis Centre, Department of Pediatric Pulmonology and Neonatology, Medizinische Hochschule Hannover, Germany
– sequence: 2
  givenname: Javier
  surname: Sanz
  fullname: Sanz, Javier
  email: derichs.nico@mh-hannover.de
  organization: Division of Human Genetics, Department of Pediatrics, Inselspital, University of Bern, Switzerland
– sequence: 3
  givenname: Thomas
  surname: Von Kanel
  fullname: Von Kanel, Thomas
  email: derichs.nico@mh-hannover.de
  organization: Division of Human Genetics, Department of Pediatrics, Inselspital, University of Bern, Switzerland
– sequence: 4
  givenname: Cornelia
  surname: Stolpe
  fullname: Stolpe, Cornelia
  email: derichs.nico@mh-hannover.de
  organization: Cystic Fibrosis Centre, Department of Pediatric Pulmonology and Neonatology, Medizinische Hochschule Hannover, Germany
– sequence: 5
  givenname: Antonia
  surname: Zapf
  fullname: Zapf, Antonia
  email: derichs.nico@mh-hannover.de
  organization: Institute for Biometry, Medizinische Hochschule Hannover, Germany
– sequence: 6
  givenname: Burkhard
  surname: Tümmler
  fullname: Tümmler, Burkhard
  email: derichs.nico@mh-hannover.de
  organization: Cystic Fibrosis Centre, Department of Pediatric Pulmonology and Neonatology, Medizinische Hochschule Hannover, Germany
– sequence: 7
  givenname: Sabina
  surname: Gallati
  fullname: Gallati, Sabina
  email: derichs.nico@mh-hannover.de
  organization: Division of Human Genetics, Department of Pediatrics, Inselspital, University of Bern, Switzerland
– sequence: 8
  givenname: Manfred
  surname: Ballmann
  fullname: Ballmann, Manfred
  email: derichs.nico@mh-hannover.de
  organization: Cystic Fibrosis Centre, Department of Pediatric Pulmonology and Neonatology, Medizinische Hochschule Hannover, Germany
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23009548$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20627915$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtr3DAUhUVJaSZp190VQQmFgieSZVtydyH0EQhkk66Fno0GW5pKdpP8hP7r3hlPKARKV7qI75x7OecEHcUUHUJvKVlTyrrz6e5hXRPSr2ndEiFeoBVtOlGxuu-O0IqQhlQd490xOillQwgRlPJX6LgmXc172q7Q76s4uTKFqAZs5pxdnPDoVJmzG3ezTxnboH7EBJDBZlClBB-MmkKKOHm8hQnAgu_DdId_zjuzFJUeHDaPe40POqcSyif8Sw3BLkoVLc7OO1hoHIZP9Rq99Goo7s3hPUXfv3y-vfxWXd98vbq8uK50w8hU9Z2gotFWeN3o3mnWaGc14YzYrlW8awFzra1tQ42nDWWCCQesElpwXht2ij4svtuc9ufKMRTjhkFFl-YiOWM9Fz1pgXz_jNykOUNSRVIOV9QMDIF6d6BmPTortzmMKj_Kp4wBODsAqhg1-KyiCeUvx6C_thHAtQtnIK4C4UgTpn1aU1ZhkJTIXecSOpe7zuXSOejOn-merP-t-Lgo9Lj5L_wHCDi9-A
CODEN THORA7
CitedBy_id crossref_primary_10_1183_13993003_00209_2022
crossref_primary_10_1016_j_pan_2024_03_005
crossref_primary_10_1080_17476348_2023_2213438
crossref_primary_10_1128_spectrum_03633_22
crossref_primary_10_1016_j_jcf_2018_02_007
crossref_primary_10_18093_0869_0189_2024_34_6_857_868
crossref_primary_10_3390_genes14091705
crossref_primary_10_3390_ijms24065199
crossref_primary_10_3390_ijms222413472
crossref_primary_10_1371_journal_pone_0106842
crossref_primary_10_1016_j_jcf_2016_10_009
crossref_primary_10_1097_MPG_0000000000001366
crossref_primary_10_1016_j_isci_2021_103710
crossref_primary_10_1183_13993003_02529_2017
crossref_primary_10_3390_ijms25052770
crossref_primary_10_3233_TRD_180026
crossref_primary_10_1164_rccm_201710_1983OC
crossref_primary_10_1007_s10405_013_0762_8
crossref_primary_10_1016_j_isci_2023_108180
crossref_primary_10_18093_0869_0189_2024_34_2_264_270
crossref_primary_10_1016_j_jcf_2022_09_011
crossref_primary_10_1016_S1569_1993_11_60014_3
crossref_primary_10_1002_ppul_23146
crossref_primary_10_4161_rdis_27112
crossref_primary_10_1136_bmjresp_2020_000736
crossref_primary_10_17816_gc624124
crossref_primary_10_3390_cimb44100349
crossref_primary_10_1016_j_pharmthera_2014_06_005
crossref_primary_10_3390_ijns6010019
crossref_primary_10_1186_1471_2466_14_44
crossref_primary_10_1016_j_jcf_2022_09_005
crossref_primary_10_1126_scitranslmed_aad8278
crossref_primary_10_1186_s40248_018_0142_7
crossref_primary_10_1002_ppul_22586
crossref_primary_10_1002_ppul_23553
crossref_primary_10_3390_jpm12081321
crossref_primary_10_3390_ijms24076351
crossref_primary_10_1080_17474124_2022_2084072
crossref_primary_10_1016_j_prrv_2015_05_004
crossref_primary_10_1515_labmed_2016_0062
crossref_primary_10_1016_j_ccm_2015_10_005
crossref_primary_10_18093_0869_0189_2023_33_2_233_242
crossref_primary_10_7326_M22_1741
crossref_primary_10_1016_S0140_6736_20_32542_3
crossref_primary_10_1183_09059180_00008412
crossref_primary_10_1371_journal_pone_0022212
crossref_primary_10_1016_j_jcf_2021_06_012
crossref_primary_10_3390_ijms231810377
crossref_primary_10_1016_j_jcf_2021_12_010
crossref_primary_10_1183_23120541_00096_2015
crossref_primary_10_1016_j_jcf_2011_03_009
crossref_primary_10_1007_s40142_017_0122_9
crossref_primary_10_12998_wjcc_v7_i22_3757
crossref_primary_10_3390_ijms251910424
crossref_primary_10_1371_journal_pone_0073905
crossref_primary_10_1016_j_bbadis_2010_08_001
crossref_primary_10_1016_S1569_1993_11_60009_X
crossref_primary_10_18093_0869_0189_2024_34_2_283_288
crossref_primary_10_3389_fphar_2018_01429
crossref_primary_10_1016_j_gene_2020_145023
crossref_primary_10_1177_20406223221108627
crossref_primary_10_3390_ijms23031437
crossref_primary_10_1016_j_jcf_2014_05_007
crossref_primary_10_1183_09031936_00057512
crossref_primary_10_3389_fphar_2023_1188051
crossref_primary_10_1016_j_arcped_2017_07_015
crossref_primary_10_1183_23120541_00227_2022
crossref_primary_10_1016_j_prrv_2015_11_007
crossref_primary_10_1016_j_jcf_2015_01_006
crossref_primary_10_1016_j_lpm_2017_04_010
crossref_primary_10_18093_0869_0189_2023_33_2_182_188
crossref_primary_10_1002_ppul_26179
crossref_primary_10_1016_j_jcf_2018_03_012
crossref_primary_10_31146_2949_4664_apps_2_1_142_147
crossref_primary_10_1371_journal_pone_0024445
crossref_primary_10_1016_j_bbagen_2014_07_010
crossref_primary_10_1001_jama_2018_21998
crossref_primary_10_1016_j_jcf_2022_10_002
crossref_primary_10_1186_s12874_015_0025_y
crossref_primary_10_3390_genes12060837
crossref_primary_10_1016_j_jcf_2016_06_009
crossref_primary_10_1080_21678707_2017_1393413
crossref_primary_10_1186_1471_2466_14_156
crossref_primary_10_1186_s12887_024_05154_7
crossref_primary_10_1016_j_dld_2014_06_011
crossref_primary_10_1055_s_0042_1759881
crossref_primary_10_1016_j_arcped_2017_01_019
crossref_primary_10_1186_1471_230X_13_91
crossref_primary_10_1136_thoraxjnl_2020_216368
crossref_primary_10_3390_jpm11050384
crossref_primary_10_31178_rbbs_2021_4_1_3
crossref_primary_10_1016_j_jcf_2012_12_014
crossref_primary_10_3390_ijms25010114
crossref_primary_10_1016_j_prrv_2019_02_004
crossref_primary_10_18093_0869_0189_2021_31_2_167_177
crossref_primary_10_1016_j_jpeds_2016_09_067
crossref_primary_10_18786_2072_0505_2021_49_019
crossref_primary_10_18093_0869_0189_2021_31_2_178_188
crossref_primary_10_1016_j_jpeds_2016_09_065
crossref_primary_10_1016_j_jpeds_2016_09_064
crossref_primary_10_1016_j_jpeds_2016_09_062
ContentType Journal Article
Copyright 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
2015 INIST-CNRS
Copyright: 2010 (c) 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Copyright_xml – notice: 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
– notice: 2015 INIST-CNRS
– notice: Copyright: 2010 (c) 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
BTHHO
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1136/thx.2009.125088
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
BMJ Journals
ProQuest One Community College
Health Research Premium Collection (ProQuest)
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Proquest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
BMJ Journals
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
ProQuest One Academic Middle East (New)
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-3296
EndPage 599
ExternalDocumentID 4027008951
20627915
23009548
10_1136_thx_2009_125088
thoraxjnl
Genre Validation Studies
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Germany
GeographicLocations_xml – name: Germany
GroupedDBID ---
.55
.GJ
.VT
08G
0R~
123
18M
29Q
2WC
354
39C
3O-
4.4
40O
53G
5RE
5VS
6PF
7X7
7~S
88E
8F7
8FI
8FJ
8R4
8R5
AAHLL
AAKAS
AAOJX
AAWJN
AAWTL
AAYEP
ABAAH
ABJNI
ABKDF
ABMQD
ABOCM
ABTFR
ABUWG
ABVAJ
ACGFO
ACGFS
ACGTL
ACHTP
ACMFJ
ACOAB
ACOFX
ACQSR
ACTZY
ADBBV
ADCEG
ADZCM
AENEX
AFKRA
AFWFF
AGQPQ
AHMBA
AHNKE
AHQMW
AJYBZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AZFZN
BAWUL
BENPR
BLJBA
BOMFT
BPHCQ
BTFSW
BTHHO
BVXVI
C45
CAG
CCPQU
COF
CS3
CXRWF
DIK
DU5
E3Z
EBS
EJD
F5P
FEDTE
FYUFA
GX1
H13
HAJ
HMCUK
HVGLF
HYE
HZ~
IAO
IEA
IH2
IHR
IOF
ITC
J5H
KQ8
L7B
M1P
N4W
N9A
NTWIH
NXWIF
O9-
OK1
OVD
P2P
PHGZT
PQQKQ
PROAC
PSQYO
Q2X
R53
RHI
RMJ
RPM
RV8
TEORI
TR2
UAW
UKHRP
UYXKK
V24
VM9
VVN
W8F
WH7
X7M
YFH
YOC
YQY
ZCG
ZGI
AAYXX
ACQHZ
ADGHP
AERUA
CITATION
PHGZM
IQODW
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
PUEGO
ID FETCH-LOGICAL-b430t-968184bd8fb4b9eb34bedb0730d65a765b43e5d2d41cf1413838efb4a8b8772c3
IEDL.DBID 7X7
ISSN 0040-6376
1468-3296
IngestDate Fri Sep 05 12:43:17 EDT 2025
Fri Jul 25 09:45:23 EDT 2025
Thu Apr 03 07:08:47 EDT 2025
Mon Jul 21 09:15:08 EDT 2025
Tue Jul 01 02:31:22 EDT 2025
Thu Apr 24 22:53:00 EDT 2025
Thu Apr 24 23:02:57 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Human
Validation
Respiratory disease
Reference
Gut
Metabolic diseases
Patient
Cystic fibrosis
Data
Genetic disease
Current measurement
Classification
Digestive diseases
Anesthesia
Circulatory system
Diagnosis
Cardiology
Pancreatic disease
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b430t-968184bd8fb4b9eb34bedb0730d65a765b43e5d2d41cf1413838efb4a8b8772c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://thorax.bmj.com/content/thoraxjnl/65/7/594.full.pdf
PMID 20627915
PQID 1781823772
PQPubID 2041050
PageCount 6
ParticipantIDs proquest_miscellaneous_733978905
proquest_journals_1781823772
pubmed_primary_20627915
pascalfrancis_primary_23009548
crossref_citationtrail_10_1136_thx_2009_125088
crossref_primary_10_1136_thx_2009_125088
bmj_primary_10_1136_thx_2009_125088
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-07-01
PublicationDateYYYYMMDD 2010-07-01
PublicationDate_xml – month: 07
  year: 2010
  text: 2010-07-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Thorax
PublicationTitleAlternate Thorax
PublicationYear 2010
Publisher BMJ Publishing Group
BMJ Publishing Group LTD
Publisher_xml – name: BMJ Publishing Group
– name: BMJ Publishing Group LTD
References Hirtz, Gonska, Seydewitz 2004; 127
Castellani, Cuppens, Macek 2008; 7
Ratjen, Döring 2003; 361
de Jonge, Ballmann, Veeze 2004; 3
Dohle, Veeze, Overbeek 1999; 14
Derichs, Mekus, Bronsveld 2004; 55
Bronsveld, Mekus, Bijman 2001; 108
Desmarquest, Feldmann, Tamalat 2000; 118
Rosenstein 2003; 36
Wilschanski, Famini, Strauss-Liviatan 2001; 17
Wilschanski, Dupuis, Ellis 2006; 174
Amaral, Clarke, Ramalho 2004; 3
Mayell, Munck, Craig 2009; 8
Stewart, Zabner, Shuber 1995; 151
Goubau, Wilschanski, Skalicka 2009; 64
Veeze, Halley, Bijman 1994; 93
Boyle 2003; 9
Bronsveld, Bijman, Mekus 1999; 54
Farrell, Rosenstein, White 2008; 153
De Boeck, Wilschanski, Castellani 2006; 61
van Barneveld, Stanke, Ballmann 2006; 1762
Veeze, Sinaasappel, Bijman 1991; 101
Stanke, Ballmann, Bronsveld 2008; 45
Liechti-Gallati, Schneider, Neeser 1999; 7
Derichs, Schuster, Grund 2005; 67
Cuppens, Lin, Jaspers 1998; 101
Chu, Trapnell, Curristin 1993; 3
Highsmith, Burch, Zhou 1994; 331
Bronsveld, Mekus, Bijman 2000; 119
Knowles, Durie 2002; 347
Rosenstein, Cutting 1998; 132
Ockenga, Stuhrmann, Ballmann 2000; 95
20627911 - Thorax. 2010 Jul;65(7):575-6
References_xml – volume: 132
  start-page: 589
  year: 1998
  article-title: The diagnosis of cystic fibrosis: a consensus statement
  publication-title: J Pediatr
– volume: 347
  start-page: 439
  year: 2002
  article-title: What is cystic fibrosis?
  publication-title: N Engl J Med
– volume: 17
  start-page: 1208
  year: 2001
  article-title: Nasal potential difference measurements in patients with atypical cystic fibrosis
  publication-title: Eur Respir J
– volume: 45
  start-page: 47
  year: 2008
  article-title: Diversity of the basic defect of homozygous CFTR mutation genotypes in humans
  publication-title: J Med Genet
– volume: 8
  start-page: 71
  year: 2009
  article-title: A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis
  publication-title: J Cyst Fibros
– volume: 7
  start-page: 590
  year: 1999
  article-title: Two buffer PAGE system-based SSCP/HD analysis: a general protocol for rapid and sensitive mutation screening in cystic fibrosis and any other human genetic disease
  publication-title: Eur J Hum Genet
– volume: 95
  start-page: 2061
  year: 2000
  article-title: Mutations of the cystic fibrosis gene but not cationic trypsinogen gene are associated with recurrent or chronic idiopathic pancreatitis
  publication-title: Am J Gastroenterol
– volume: 36
  start-page: 10
  year: 2003
  article-title: Nonclassic cystic fibrosis: a clinical conundrum
  publication-title: Pediatr Pulmonol
– volume: 3
  start-page: 17
  year: 2004
  article-title: Quantitative methods for the analysis of CFTR transcripts/splicing variants
  publication-title: J Cyst Fibros
– volume: 331
  start-page: 974
  year: 1994
  article-title: A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations
  publication-title: N Engl J Med
– volume: 93
  start-page: 461
  year: 1994
  article-title: Determinants of mild clinical symptoms in cystic fibrosis patients: residual chloride secretion measured in rectal biopsies in relation to the genotype
  publication-title: J Clin Invest
– volume: 118
  start-page: 1591
  year: 2000
  article-title: Genotype analysis and phenotypic manifestations of children with intermediate sweat chloride test results
  publication-title: Chest
– volume: 14
  start-page: 371
  year: 1999
  article-title: The complex relationships between cystic fibrosis and congenital bilateral absence of the vas deferens: clinical, electrophysiological and genetic data
  publication-title: Hum Reprod
– volume: 3
  start-page: 151
  year: 1993
  article-title: Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA
  publication-title: Nat Genet
– volume: 127
  start-page: 1085
  year: 2004
  article-title: CFTR Cl− channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis
  publication-title: Gastroenterology
– volume: 3
  start-page: 159
  year: 2004
  article-title: Ex vivo CF diagnosis by intestinal current measurements (ICM) in small aperture, circulating Ussing chambers
  publication-title: J Cyst Fibros
– volume: 61
  start-page: 627
  year: 2006
  article-title: Cystic fibrosis: terminology and diagnostic algorithms
  publication-title: Thorax
– volume: 174
  start-page: 787
  year: 2006
  article-title: Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials
  publication-title: Am J Respir Crit Care Med
– volume: 9
  start-page: 498
  year: 2003
  article-title: Nonclassic cystic fibrosis and CFTR-related diseases
  publication-title: Curr Opin Pulm Med
– volume: 55
  start-page: 69
  year: 2004
  article-title: Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients
  publication-title: Pediatr Res
– volume: 101
  start-page: 398
  year: 1991
  article-title: Ion transport abnormalities in rectal suction biopsies from children with cystic fibrosis
  publication-title: Gastroenterology
– volume: 151
  start-page: 899
  year: 1995
  article-title: Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis
  publication-title: Am J Respir Crit Care Med
– volume: 54
  start-page: 278
  year: 1999
  article-title: Clinical presentation of exclusive cystic fibrosis lung disease
  publication-title: Thorax
– volume: 1762
  start-page: 393
  year: 2006
  article-title: Ex vivo biochemical analysis of CFTR in human rectal biopsies
  publication-title: Biochim Biophys Acta
– volume: 153
  start-page: S4
  year: 2008
  article-title: Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report
  publication-title: J Pediatr
– volume: 108
  start-page: 1705
  year: 2001
  article-title: Chloride conductance and genetic background modulate the cystic fibrosis phenotype of ΔF508 homozygous twins and siblings
  publication-title: J Clin Invest
– volume: 64
  start-page: 683
  year: 2009
  article-title: Phenotypic characterization of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis
  publication-title: Thorax
– volume: 67
  start-page: 529
  year: 2005
  article-title: Homozygosity for L997F in a child with normal clinical and chloride secretory phenotype provides evidence that this Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) mutation does not cause cystic fibrosis
  publication-title: Clin Genet
– volume: 119
  start-page: 32
  year: 2000
  article-title: Residual chloride secretion in intestinal tissue of ΔF508 homozygous twins and siblings with cystic fibrosis
  publication-title: Gastroenterology
– volume: 101
  start-page: 487
  year: 1998
  article-title: Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes: the polymorphic (TG)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation
  publication-title: J Clin Invest
– volume: 7
  start-page: 179
  year: 2008
  article-title: Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice
  publication-title: J Cyst Fibros
– volume: 361
  start-page: 681
  year: 2003
  article-title: Cystic fibrosis
  publication-title: Lancet
– reference: 20627911 - Thorax. 2010 Jul;65(7):575-6
SSID ssj0008117
Score 2.3718042
Snippet BackgroundIn questionable cystic fibrosis (CF), mild or monosymptomatic phenotypes frequently cause diagnostic difficulties despite detailed algorithms. CF...
In questionable cystic fibrosis (CF), mild or monosymptomatic phenotypes frequently cause diagnostic difficulties despite detailed algorithms. CF transmembrane...
Background In questionable cystic fibrosis (CF), mild or monosymptomatic phenotypes frequently cause diagnostic difficulties despite detailed algorithms. CF...
SourceID proquest
pubmed
pascalfrancis
crossref
bmj
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 594
SubjectTerms Adolescent
Adult
Anesthesia
Biological and medical sciences
Biopsy
Cardiology. Vascular system
Child
Child, Preschool
Chlorides - metabolism
Cystic fibrosis
Cystic Fibrosis - diagnosis
Cystic Fibrosis Transmembrane Conductance Regulator - genetics
Cystic Fibrosis Transmembrane Conductance Regulator - physiology
Disease
Errors of metabolism
Female
Genotype
Humans
Infant
Male
Medical sciences
Membrane Potentials - physiology
Metabolic diseases
Middle Aged
Miscellaneous hereditary metabolic disorders
Mutation
Pneumology
Rectum - physiopathology
Reference Values
Reproducibility of Results
Suctioning
Sweat - metabolism
Young Adult
Title Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data
URI https://thorax.bmj.com/content/65/7/594.full
https://www.ncbi.nlm.nih.gov/pubmed/20627915
https://www.proquest.com/docview/1781823772
https://www.proquest.com/docview/733978905
Volume 65
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bS91AEB6qQimI2JumtYeF9qEvqUl2s0n6UmpRpKCIVDhvIXtDRZOjOYL-hP5rZ7J7cvDB9jm7Q9iZ3bns7PcBfMl40eSqsbGWXMWCZzourRJ0-2i4rhy3GT1wPjqWh2fi9zSfhoJbH9oqF2ficFCbTlONfDct0LWg5CL7MbuJiTWKblcDhcYKrKUYiRB1QzEdE66EHlEuuuYk7qQA7ZNyuTs_v_dglejgE6JdWVHXl0980_qs6XGZnOe3eD4AHRzRwSZshAiS_fQqfw0vbPsGXh6FO_K38JeKfLhxaZD26EvselkJZBilMuMb7FAC0xQ-U7_QoCLWORagVntGNVo2_AzVC9WVZfphmOMwx-76i_47Qzu98KxMrGkNG0lLGHWevoOzg_0_vw7jQLgQK8GTeVxJXGOhTOmUUBWm2UJZo-gQMDJvCpnjMJubzIhUuxTdX8lLi2ObUpWoGM3fw2rbtXYbWMK1LVSaKOmMUC6tnCzRHRNcvMqyqojgMy54PfOQGvWQinBZo1qIGLOqvVoi-LZQSK0DZjlRZ1w9P-HrOOG_sidPNDyOx6QsIRi8CHYWKq_Dxu7rpRlGwMbPuCXpnqVpbXfX1wXHIK-skjyCLW8pS9mECl2l-Yd_y_4Ir3yXArUF78Dq_PbOfsLgZ64mg4VPYG1v__jk9BFo8AVG
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9VAEB7aU1BBxLvRWhdU8CVtkk02iVDES8up7TmItNC3mL2EtrTJ0Zyi_Qn-KX-bM9lNDn2oPvU5u8OSmZ2dmZ39PoBXEU_LRJbGV4JLP-aR8jMjY7p91FzlFTcRPXCeTMX4IP58mBwuwZ_-LQy1VfY-sXPUulFUI98IUzxaUHIavZt994k1im5XewqN0lEr6M0OYsw97Ng1Fz8xhWs3dz6hvl9H0fbW_sex71gGfBnzYO7nAgXHUmeVjGWOuWUsjZZk-VokZSoSHGYSHek4VFWIPj_jmcGxZSYzXI3iKHcZVmIqoIxg5cPW9MvX4SygZ5x9357AvezAhUIuNuZHvyxcJoYYARG_LMuzk0un4-1Z2aKiKsuwcXUI3B2F23fhjoth2XtrdPdgydT34cbE3dI_gN9UZkTXQYOUxX9iZ4taJMM4mWnb4ocSmKIAnjqWOiNhTcUc2GvLqErMusVQxVKeGqYuujkVZvlNe9y-ZbhTji0vFCtrzQbaFEa9rw_h4FqU8QhGdVObJ8ACrkwqw0CKSseyCvNKZBgQEGC9jKI89eAl_vBiZkE9ii4Z4qJAtRA1Z15YtXiw3iukUA41ncg7Tq-e8GaY8F_Za5c0PIzHtDAgID4PVnuVF861tMViI3jAhs_oFOimp6xNc94WKccwM8uDxIPH1lIWsgmXOg-Tp_-W_QJujvcne8XeznT3GdyyPRPUpLwKo_mPc_McQ7G5XHP2zuDbdW-xv0_0R1Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFD70AkUQ8W601gEVfImbZJJJIhRR26W1dilioW9p5oaVNruaLdqf4F_zV3lOZpKlD9WnPmfmJOTMuc2c-T6AFwnP60zWJlSCyzDliQoLI1M6fdRclZabhC4470_EzmH68Sg7WoI__V0YaqvsfWLnqPVU0R75KM4xtKDkPBlZ3xZxsDV-O_seEoMUnbT2dBq1p1nQmx3cmL_ksWcufmI5127ubqHuXybJePvLh53QMw6EMuXRPCwFviSVurAylSXWmak0WpIVaJHVuchwmMl0otNY2Rj9f8ELg2PrQhb4ZYqj3GVYzTHqYyG4-n57cvB5iAt0pbPv4RNo1x5oKOZiNP_6y0FnYroREQnMsjz7dilS3pzVLSrNOraNq9PhLiyOb8Mtn8-yd24B3oEl09yFtX1_Yn8PftOWI7oRGqQcFhQ7W-xLMsyZmXbtfiiBKUrmqXupWzBsapkHfm0Z7Riz7mNo91KeGqYuujkWK_5pe9K-YWg1J44jitWNZgOFCqM-2PtweC3KeAArzbQxj4BFXJlcxpEUVqfSxqUVBSYHBF4vk6TMA3iOP7yaOYCPqiuMuKhQLUTTWVZOLQG87hVSKY-gTkQep1dPeDVM-K_sjUsaHsZjiRgRKF8A673KK-9m2mphFAGw4TE6CDr1qRszPW-rnGPKWZRRFsBDt1IWsgmjuoyzx_-W_QzW0NSqT7uTvSdww7VPUL_yOqzMf5ybp5iVzeWGX-4Mjq_bwv4Cr19LmA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intestinal+current+measurement+for+diagnostic+classification+of+patients+with+questionable+cystic+fibrosis%3A+validation+and+reference+data&rft.jtitle=Thorax&rft.au=Derichs%2C+Nico&rft.au=Sanz%2C+Javier&rft.au=Von+Kanel%2C+Thomas&rft.au=Stolpe%2C+Cornelia&rft.date=2010-07-01&rft.eissn=1468-3296&rft.volume=65&rft.issue=7&rft.spage=594&rft_id=info:doi/10.1136%2Fthx.2009.125088&rft_id=info%3Apmid%2F20627915&rft.externalDocID=20627915
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0040-6376&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0040-6376&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0040-6376&client=summon